Polarityte Inc (OQ:PTE)

Business Focus: Biotechnology & Medical Research

INK Ultra Money Free

Latest 10 SEC filings (by transaction date) for PTE within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET August 9th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Aug 5/20 Aug 4/20 Lough Denver Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -3,194 $1.61
Aug 5/20 Aug 3/20 Lough Denver Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 11,111  
Jul 31/20 Jul 29/20 Shen Jessica Xiaolin Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) -102,662  
Jul 31/20 Jul 29/20 Shen Jessica Xiaolin Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 37,838  
Jul 20/20 Jul 16/20 Hague Richard Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -10,546 $1.52
Jul 20/20 Jul 16/20 Hoyler Cameron J. Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -8,644 $1.52
Jul 20/20 Jul 16/20 Seaburg David B Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -21,179 $1.52
Jul 6/20 Jul 2/20 Lough Denver Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -3,252 $1.27
Jul 6/20 Jul 1/20 Cohen Peter A Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 29,330 $1.27
Jul 6/20 Jul 1/20 Dyer Jeffrey Hansen Direct Ownership Stock option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 8,700 $0.876
Sign up or login above to see all SEC filings within the past 6 months.
Latest 10 SEC filings (by filing date) for PTE within the last 6 months [?]
Amended Filing      Footnote and/or Remark
As of 11:59pm ET August 9th, 2020
Filing
Date
Transaction
Date
Insider Name Ownership
Type
Securities Nature of transaction Volume or Value Price
Aug 5/20 Aug 4/20 Lough Denver Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -3,194 $1.61
Aug 5/20 Aug 3/20 Lough Denver Direct Ownership Common Stock M - Exercise or conversion exempt under rule 16b-3 11,111  
Jul 31/20 Jul 29/20 Shen Jessica Xiaolin Direct Ownership Stock Option (right to buy) A - Grant, award or other under Rule 16b-3(d) -102,662  
Jul 31/20 Jul 29/20 Shen Jessica Xiaolin Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 37,838  
Jul 20/20 Jul 16/20 Hague Richard Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -10,546 $1.52
Jul 20/20 Jul 16/20 Hoyler Cameron J. Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -8,644 $1.52
Jul 20/20 Jul 16/20 Seaburg David B Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -21,179 $1.52
Jul 6/20 Jul 1/20 Cohen Peter A Direct Ownership Common Stock A - Grant, award or other under Rule 16b-3(d) 29,330 $1.27
Jul 6/20 Jul 1/20 Dyer Jeffrey Hansen Direct Ownership Stock option (Right to Buy) A - Grant, award or other under Rule 16b-3(d) 8,700 $0.876
Jul 6/20 Jul 2/20 Lough Denver Direct Ownership Common Stock F - Payment of exercise price or tax liability, exercise or vesting of a security under Rule 16b-3 -3,252 $1.27
Sign up or login above to see all SEC filings within the past 6 months.
Sign up or login above to see the past 6 months of filings sorted by insider. .
Get holdings trends & enhanced insider charts in PDF now

Twitter

Search (past week) for $PTE

Competitors

Competitors with Recent Insider Filings
Iqvia Holdings (N:IQV)
Moderna (OQ:MRNA)
Biohaven Pharmaceutical H (N:BHVN)

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please subscribe. Our packages start at $1.00 plus tax for the first month.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.